Determination of the GABAB receptor agonist CGP 44532 (3-amino-2-hydroxypropylmethylphosphinic acid) in rat plasma after pre-column derivatization by micro-high-performance liquid chromatography combined with negative electrospray tandem mass spectrometry

被引:11
作者
Blum, W
Aichholz, R
Ramstein, P
Kühnöl, J
Froestl, W
Desrayaud, S
机构
[1] Novartis Pharma AG, Dept Res, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Dept Dev, CH-4002 Basel, Switzerland
来源
JOURNAL OF CHROMATOGRAPHY B | 2000年 / 748卷 / 02期
关键词
3-amino-2-hydroxypropylmethylphosphininc acid; nitrobenzylcarbamate isopropylidene derivative;
D O I
10.1016/S0378-4347(00)00352-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An assay, based on pre-column derivatization and micro-high-performance liquid chromatography-tandem mass spectrometry, was developed for the determination of the GABA, agonist CGP 44532 in rat plasma. CGP 44532, a highly polar 3-amino-2(S)-hydroxypropylmethylphosphinic acid, presented difficulties in developing a chromatographic method for the analysis of the compound in rat plasma. Instead of analyzing the target compound directly, it was derivatized prior to separation to a 4-nitrobenzylcarbamate isopropyliden derivative. In order to reach the required quantitation limit, on-line solid-phase extraction was utilized for sample clean-up and reversed-phase micro-column high-performance liquid chromatography, for separation of the plasma samples. The separated compounds were detected by negative electrospray tandem mass spectrometry in selected reaction monitoring mode. The derivatives show good chromatographic and mass spectrometric properties and both the target compound and the internal standard, could be eluted as symmetrical peaks with good signal/noise ratio. The MS-MS detection was selective and sensitive due to the straight fragmentation pattern. After injection of 200-mul sample aliquots, the limit of quantification was 10 ng ml(-1). The analytical assay is useable in the range of 10-500 ng ml(-1). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 19 条
[1]   CHIRAL CHLOROFORMATES AS TRANSPARENT REAGENTS FOR THE RESOLUTION OF METOPROLOL ENANTIOMERS BY REVERSED-PHASE LIQUID-CHROMATOGRAPHY [J].
AHNOFF, M ;
CHEN, S ;
GREEN, A ;
GRUNDEVIK, I .
JOURNAL OF CHROMATOGRAPHY, 1990, 506 :593-599
[2]   DERIVATIZATION IN MASS-SPECTROMETRY - STRATEGIES FOR CONTROLLING FRAGMENTATION [J].
ANDEREGG, RJ .
MASS SPECTROMETRY REVIEWS, 1988, 7 (04) :395-424
[3]  
Birkmayer W, 1972, SPASTICITY TOPICAL S
[4]   Application of capillary gas chromatography to the study of hydrolysis of the nerve agent VX in rat plasma [J].
Bonierbale, E ;
Debordes, L ;
Coppet, L .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1997, 688 (02) :255-264
[5]   GABAB receptors - Role and therapeutic implications in CNS disorders [J].
Bowery, NG ;
Kerr, DIB ;
Ong, J .
CNS DRUGS, 1997, 7 (03) :167-175
[6]   GABA-A AND GABA-B RECEPTOR-SITE DISTRIBUTION IN THE RAT CENTRAL-NERVOUS-SYSTEM [J].
BOWERY, NG ;
HUDSON, AL ;
PRICE, GW .
NEUROSCIENCE, 1987, 20 (02) :365-383
[7]   (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL ;
DOBLE, A ;
MIDDLEMISS, DN ;
SHAW, J ;
TURNBULL, M .
NATURE, 1980, 283 (5742) :92-94
[8]   USE OF CHROMOGENIC AND FLUORESCENT OXYCARBONYL CHLORIDES AS REAGENTS FOR AMINO-ACID-ANALYSIS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BRUCKNER, H ;
LUPKE, M .
JOURNAL OF CHROMATOGRAPHY A, 1995, 697 (1-2) :295-307
[9]   SEPARATION OF SULFUR-CONTAINING CHEMICAL WARFARE RELATED-COMPOUNDS IN AQUEOUS SAMPLES BY MICELLAR ELECTROKINETIC CHROMATOGRAPHY [J].
CHEICANTE, RL ;
STUFF, JR ;
DURST, HD .
JOURNAL OF CHROMATOGRAPHY A, 1995, 711 (02) :347-352
[10]   PHOSPHINIC ACID ANALOGS OF GABA .1. NEW POTENT AND SELECTIVE GABA(B) AGONISTS [J].
FROESTL, W ;
MICKEL, SJ ;
HALL, RG ;
VONSPRECHER, G ;
STRUB, D ;
BAUMANN, PA ;
BRUGGER, F ;
GENTSCH, C ;
JAEKEL, J ;
OLPE, HR ;
RIHS, G ;
VASSOUT, A ;
WALDMEIER, PC ;
BITTIGER, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3297-3312